Medical Weight Loss, Guided by a Physician
Weight Management plans designed to improve your health, metabolism, and long-term results.
Services Included
• GLP-1 medications (when medically appropriate) • Obesity and overweight management • Metabolic syndrome treatment • Insulin resistance management • Nutritional guidance and counseling
How It Works
Initial Consultation
A physician evaluates your medical history, lifestyle, and weight loss goals.
Personalized Plan
You receive a treatment plan that may include medications, nutrition guidance, and lifestyle recommendations.
Ongoing Support
Follow-up visits help track progress, adjust treatment, and ensure safe, effective results.
Who This Is For:
This program may be a good fit if you.
Struggle with weight loss despite diet and exercise
Have metabolic concerns or insulin resistance
Are overweight or obese
Want a medically supervised, structured plan
Initial consultation + prescription
$150
Weight loss follow-up + prescription
$100
Medication costs are separate and prescribed when appropriate
Semaglutide is a GLP-1 receptor agonist that mimics a single natural hormone involved in blood sugar control and appetite regulation. It works by increasing insulin release, slowing stomach emptying, and reducing hunger signals. It’s used for type 2 diabetes and weight management, typically as a once-weekly injection, and is well established with strong weight loss and glucose-lowering effects.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it mimics two hormones instead of one. This dual action enhances insulin response, further suppresses glucagon, and more powerfully reduces appetite. It’s also used for type 2 diabetes and weight management, given once weekly, and often produces greater weight loss and metabolic improvement compared to GLP-1–only medications like semaglutide.
Take control of your health with physician-guided weight loss.
Safety & Medical Disclaimer
• All treatments are based on physician evaluation.
• Medications are prescribed only when medically appropriate.
• Individual results may vary.
Retatrutide is an experimental once-weekly injectable medication being studied for obesity and type 2 diabetes. It works by activating GLP-1, GIP, and glucagon receptors—three hormone pathways involved in appetite control, blood sugar regulation, and energy use. Early studies have shown significant weight loss and promising metabolic benefits.
It is not yet FDA approved because it is still in clinical trials to confirm long-term safety, effectiveness, and proper dosing before review by the U.S. Food and Drug Administration. At Twin Pines Physicians, we are watching the clinical trials closely and will offer it once the FDA deems it safe.